These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 20073283)

  • 21. A randomized, comparative safety study of a prefilled plastic and user-filled paper applicator with candidate microbicide tenofovir 1% gel.
    Cohen JA; Brache V; Foster J; Cochon L; Callahan M; Schwartz J
    Sex Transm Dis; 2013 Jun; 40(6):476-81. PubMed ID: 23677021
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microbicides are promoted as offering a 'female-controlled' HIV prevention method: so can they revolutionize the HIV crisis of young women in Kenya?
    Raphael MC
    J Public Health (Oxf); 2012 Dec; 34(4):625-30. PubMed ID: 23055541
    [No Abstract]   [Full Text] [Related]  

  • 23. African trial of HIV drug disappoints.
    AIDS Read; 2008 Apr; 18(4):166. PubMed ID: 18467998
    [No Abstract]   [Full Text] [Related]  

  • 24. Results of effectiveness trials of PRO 2000 gel: lessons for future microbicide trials.
    Abdool Karim SS
    Future Microbiol; 2010 Apr; 5(4):527-9. PubMed ID: 20353292
    [No Abstract]   [Full Text] [Related]  

  • 25. Update on microbicide research and development - seeking new HIV prevention tools for women.
    Mertenskoetter T; Kaptur PE
    Eur J Med Res; 2011 Jan; 16(1):1-6. PubMed ID: 21345763
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacokinetics and topical vaginal effects of two tenofovir gels in rabbits.
    Clark MR; Friend DR
    AIDS Res Hum Retroviruses; 2012 Nov; 28(11):1458-66. PubMed ID: 22394281
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The future of HIV microbicides: challenges and opportunities.
    Garg AB; Nuttall J; Romano J
    Antivir Chem Chemother; 2009; 19(4):143-50. PubMed ID: 19374141
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV transmission may be prevented by intravaginal tenofovir ring.
    Parks L
    Future Med Chem; 2012 Dec; 4(18):2239. PubMed ID: 23359902
    [No Abstract]   [Full Text] [Related]  

  • 29. Preformulation and development of a once-daily sustained-release tenofovir vaginal tablet tablet containing a single excipient.
    Mcconville C; Friend DR; Clark MR; Malcolm K
    J Pharm Sci; 2013 Jun; 102(6):1859-1868. PubMed ID: 23568749
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microbicides 2000 conference proceedings. March 13-16, 2000, Washington, DC.
    AIDS; 2001 Feb; 15 Suppl 1():S1-88. PubMed ID: 11225606
    [No Abstract]   [Full Text] [Related]  

  • 31. Promising anti-HIV gel in large-scale study in women.
    Expert Rev Anti Infect Ther; 2009 May; 7(4):395. PubMed ID: 19400755
    [No Abstract]   [Full Text] [Related]  

  • 32. Challenges of introducing vaginal microbicides in India.
    Joshi S; Kulkarni V; Paranjape R; Chandhiok N
    Indian J Med Res; 2009 May; 129(5):618-9. PubMed ID: 19675395
    [No Abstract]   [Full Text] [Related]  

  • 33. After CAPRISA 004: time to re-evaluate the HIV lexicon.
    Cates W
    Lancet; 2010 Aug; 376(9740):495-6. PubMed ID: 20709216
    [No Abstract]   [Full Text] [Related]  

  • 34. Pre-exposure prophylaxis works--it's time to deliver.
    Beyrer C; Bekker LG; Pozniak A; Barré-Sinoussi F
    Lancet; 2015 Apr; 385(9977):1482-4. PubMed ID: 25933264
    [No Abstract]   [Full Text] [Related]  

  • 35. Topical microbicides--what's new?
    Karim QA; Baxter C; Karim SA
    J Acquir Immune Defic Syndr; 2013 Jul; 63 Suppl 2():S144-9. PubMed ID: 23764627
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiretroviral drug-based microbicides to prevent HIV-1 sexual transmission.
    Klasse PJ; Shattock R; Moore JP
    Annu Rev Med; 2008; 59():455-71. PubMed ID: 17892435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Coverage, context and targeted prevention: optimising our impact.
    Aral SO; Cates W
    Sex Transm Infect; 2013 Jun; 89(4):336-40. PubMed ID: 23270932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trials of two microbicides to be launched in Africa.
    Pincock S
    BMJ; 2004 Apr; 328(7443):786. PubMed ID: 15070623
    [No Abstract]   [Full Text] [Related]  

  • 39. Preexposure prophylaxis for HIV infection.
    Siemieniuk RA; Bogoch II
    N Engl J Med; 2015 Apr; 372(18):1767-8. PubMed ID: 25923561
    [No Abstract]   [Full Text] [Related]  

  • 40. The development of vaginal microbicides for the prevention of HIV transmission.
    Weber J; Desai K; Darbyshire J;
    PLoS Med; 2005 May; 2(5):e142. PubMed ID: 15916473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.